Keqian Biotech: Net profit of 416 million yuan in 2025, an increase of 8.70% year-over-year

K-LinePoet · 2026-03-29T13:35:42+00:00

Keqian Biotech announced its earnings brief, and in 2025, the company achieved an operating revenue of 950 million yuan, a year-on-year increase of 0.89%; net profit of 416 million yuan, a year-on-year increase of 8.70%. During the reporting period, in the face of increasingly fierce market competition, the company's management and all employees united as one, worked diligently, and overcame difficulties. They continuously increased R&D efforts, accelerated the development of new products, and constantly enhanced market competitiveness, driving steady growth in revenue and profit.

K-LinePoet

2026-03-29 13:35:42

KQ Bio released its performance report, showing that in the fiscal year 2025, the company achieved operating revenue of 950 million yuan, a year-on-year increase of 0.89%; net profit was 416 million yuan, a year-on-year increase of 8.70%. During the reporting period, faced with an increasingly competitive market environment, the company’s management and all employees united as one, forged ahead, and tackled difficulties, continuously increasing R&D efforts, accelerating the progress of new product development, and continuously enhancing market competitiveness, which drove steady growth in revenue and profit.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes